title: Percutaneous mitral repair: patient selection, results, and future directions.
abstract: Percutaneous heart valve therapies are rapidly changing our approach to valvular heart diseases. Currently, mitral valve surgery is the treatment of choice for patients suffering from severe symptomatic mitral regurgitation. However surgery, because of its inherent risks, is not applicable to all patients, particularly for the elderly with comorbidities. Catheter-based mitral repair systems offer a new option to those high-risk patients. The edge-to-edge repair using the MitraClip device (Evalve, Menlo Park, CA), simulating the surgical Alfieri stitch via percutaneous approach proved to be a safe and feasible technique. This article discusses the currently available data for the MitraClip transcatheter mitral repair system.
authors.affiliation: Department of Cardiovascular Medicine, Cleveland Clinic, OH 44195, USA.
authors.forename: Uygar C
authors.initials: UC
authors.lastname: Yuksel
authors.forename: Samir R
authors.initials: SR
authors.lastname: Kapadia
authors.forename: E Murat
authors.initials: EM
authors.lastname: Tuzcu
mesh_terms: D006328:Cardiac Catheterization / Q000295:instrumentation / Q000379:methods*; D017548:Echocardiography, Transesophageal; D005471:Fluoroscopy; D019918:Heart Valve Prosthesis Implantation / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D008943:Mitral Valve / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery*; D008944:Mitral Valve Insufficiency / Q000000981:diagnostic imaging / Q000601:surgery* / Q000628:therapy; D018579:Patient Selection; D018570:Risk Assessment; D013997:Time Factors